Liverpool-based cancer research gets a £450k boost

Tuesday, 22nd August 2017 | General | 0 comments

North West Cancer Research has announced that it will provide an additional £451,000 worth of funding as part of its latest drive to boost life-saving cancer research in the Liverpool city region. 

This will take the total funding commitment from the charity to £4.2 million over the next three years for Liverpool-based research.

The latest funding will support three research projects, looking at cancer cell behaviours at a basic and therapeutic level. The projects will be based within the Institute of Integrative Biology, and the Institute of Translational Medicine at the University of Liverpool.

A two-year project looking at the effects of novel drug combinations on neuroblastoma tumours has benefitted from £117,382 to support a trainee surgeon from Alder Hey children hospital to work as a Pre-Doctoral Research Assistant and for associated consumables.

Neuroblastoma is a rare cancer of the nervous system that mostly affects children and young babies and most commonly occurs in the adrenal glands situated above the kidneys.

It can be particularly aggressive and in cases where the cancer has spread to other parts of the body it leads to large number of deaths each year.

It was most recently brought to the attention of the world by young Bradley Lowry who sadly died aged just six year’s old.

The North West Cancer Research-funded project which is a joint effort between University of Liverpool and Alder Hey Children’s Hospital NHS Foundation Trust will look at how to develop better treatment strategies to stop neuroblastoma tumour growth and dissemination.

Dr Violaine See, project lead, said: “This type of cancer has the ability to disseminate and spread to other parts of the body. When it does, these secondary tumours become difficult to treat, with poor prognosis for patients.

“New therapeutic strategies are needed to offer an alternative for conventional treatments such as chemotherapies which are often ineffective in eradicating these tumours.

“Thanks to funding from North West Cancer Research, we will be able to progress our research which will develop an advanced imaging model to determine the effectiveness of novel drug combinations.

“The overall aim will be to facilitate the identification of drugs and drug combinations for primary and secondary neuroblastoma tumours and hopefully improve the outcome of those young patients battling this deadly disease.”

Alastair Richards, CEO North West Cancer Research added: “As a charity, we pride ourselves on only backing the very best quality of research – research which will ultimately deliver significant breakthroughs and have a direct impact on people living in Liverpool and the North West.

“Cancer is one of the biggest killers in our region. Thanks to research, half of all people diagnosed with cancer today will survive.

“It is our promise to ensure a constant flow of research funding over the lifetime of the charity to ensure that in the future everyone diagnosed with cancer will have a better chance to survive.”

North West Cancer Research encourages applications for funding on a bi-annual basis. To ensure only the highest quality of research is funded, each application is extensively considered and peer-reviewed by a specially selected scientific committee comprising of leading professors, award-winning scientists and pioneering professionals.

Help us to continue fighting cancer in Merseyside by donating today.

NEWSLETTER SIGN-UP

Enter your details to be kept up to date with the latest news

Image CAPTCHA
Enter the characters shown in the image.